This fact, together with the elevated Sema4A expression observed in SSc patients [13], suggest that the Sema4A-PlexinD1 axis is responsible, at least in part, for the elevated IL-4 and IL-17 levels observed in these patients. Here, SEMA4A is linked to systemic sclerosis.